Tailored Breast Care
Increase early detection of breast cancer and decrease mortality rates
with GE HealthCare’s breast care solutions
KOIOS is the first and only patented, proprietary, clinical decision support (DS)
software using AI and machine learning to help to categorize the lesion.
Clinically proven to improve patient outcomes and streamline workflow.
Senographe Pristina sets a high bar for diagnostic confidence and performance,
leveraging the Senographe™ family’s widely recognized image quality.
Comfort for patients, confidence for technologists and clarity for radiologists.
The automated ultrasound examination of the breast with Invenia ABUS offers
an increase in sensitivity when finding invasive breast cancer in the dense breast
tissue if ABUS is used in addition to mammography.
Screening
Increased breast cancer detection
Regular mammography screening exams can reduce breast cancer mortality for women between the ages of 50-69 years by up to 35%1,2,3. Adding ABUS to mammography screening can increase sensitivity by 57% when detecting breast cancer for women with dense breasts.
Improved patient experience
SenographePristina™ was built with one objective in mind to ease patient anxiety when they enter the exam room. ABUS examination with the reverse curve transducer and the selectable compression levels reduce the patient pain*.
Faster and automated patient examination
By separating the acquisition and the interpretation of the ABUS volume, the radiologist can read the entire exam in 3 minutes.
Diagnosis
Standardized examination procedure
ABUS allows repeatable examinations in 3D and standardized bilateral evaluations. AI on LOGIQ Ultrasound systems with semi-automated segmentation and measure assistant reduces the variability of lesions categorization.
Improved accuracy with excellent image quality
cSound Image former focusing from near field to far field enables a clear depiction and analysis of the smallest tissues abnormalities. Microvascular Imaging (MVI) High-definition flow mode and 2D Shear Wave Elastography will help you with non-invasive assessment of lesion with confident measurements.
Staging
Assist in Surgical Treatment Planning
ABUS provides a full view of the breast depicting the extent of the lesion for a better surgical approach.
SonoBrightHD (CESM) offers high sensitivity imaging helping detect even the smallest lesions within the breasts.
2D Shear Wave Elastography on LOGIQ’s enables non-invasive assessment of lesion stiffness in breast.
Follow-up
Improved follow-up precision
Invenia™ ABUS 2.0 speeds up the workflow and helps with easy side-by-side comparison.
Contrast-Enhanced Ultrasound provides clear picture of tissue structure when there is a need for additional diagnosis.
The new Pristina image chain also helps reduce the exposure time in 2D with no compromiseonimage quality at low dose. Measurements taken on two SenographePristina systems consistently showed close to 30% exposure time reduction.
Non-invasive patient comfort
ABUS provides safe, non-radiation examination and reduces the cost of examination.
Breast Imaging
Exceeding your expectations
References
*ABUS disclaimer - Shah et.al.JournalofDiagnosticMedicalSonographyDOI: 10.1177/8756479313476920 2013
- Tabar L, Vitak B, Chen HH, Duffy SW, Yen MF, Chiang CF, Krusemo UB, Tot T, Smith RA. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am. 2000;38:625–651.
- Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359:909–919.
- Bjurstam N, Bjorneld L, Warwick J, Sala E, Duffy SW, Nystrom L, Walker N, Cahlin E, Eriksson O, Hafstrom LO, Lingaas H, Mattsson J, Persson S, Rudenstam CM, Salander H, Save-Soderbergh J, Wahlin T. The Gothenburg Breast Screening Trial. Cancer. 2003;97:2387–2396.